Analysis of the Ultra-Orphan Drugs Approved by the Fda in the Period 1983-2014

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Patient-Reported Outcomes in Orphan Drug Labels Approved by the US FDA

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Trends in Approvals of New Drugs With Orphan Designation in the Us (1983-2014)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2008English

A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2004English

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Section 1. Fluorine - Containing Drugs for Human Use Approved by FDA in the United States

English

Targeting the Β-Clamp in Helicobacter Pylori With FDA-approved Drugs Reveals Micromolar Inhibition by Diflunisal

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy